AJMC July 28, 2024
Buffer stocks may help mitigate drug shortages, but infrastructure and centralized management are crucial to create a long-term solution to address ongoing and future cancer drug shortages, says Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network.
Transcript
With 64% of respondents advocating for a broader buffer stock payment and more transparency from suppliers, what steps are being taken to address these needs, and how can they help mitigate future shortages?
We have also seen proposals from federal agencies around the buffer stock, which might be helpful to address future shortages by having backup stock readily available on hand to distribute when needed, if a particular drug shortage reaches a crisis level, as it did with the...
Today's Sponsors
Today's Sponsor